摘要
目的:离心机是产生生理超重力的主要手段,已被用于许多医疗目的,包括治疗精神疾病和评估飞行员的前庭系统。特别是现代离心机与以前的原始离心机相比,已经发展成机械精密的精密仪器,这表明离心机在现代医学中可能具有巨大的潜力。事实上,正在研究将离心机应用于肌肉骨骼退行性疾病,如骨质疏松症和肌肉减少症。鉴于衰老相关疾病表现在微重力条件下,包括宇航员和卧床不起的老人,推测离心机引起的超重力可能抵消这些疾病的进展是合理的。这种观点对于尚未建立激进治疗的神经退行性疾病也可能是重要的。因此,本文的主要目标是讨论离心机在空间和地球上防止中枢神经系统(CNS)疾病的潜在治疗用途。机械超引起可能对预处理,伴侣蛋白表达,突触可塑性以及神经系统中的生长和分化产生刺激作用。此外,超重力可抑制II型糖尿病(T2DM)的进展,导致抑制由T2DM引发的CNS障碍,包括神经退行性疾病,局部缺血和抑郁症。 结论:此外,超重力可能抵消微重力条件和精神疾病引起的海马神经变性。总的来说,需要进一步的研究来证明离心机引起的超重力可能有益于CNS病症的治疗
关键词: 微重力,超重力,离心机,治疗,空间,老年人,神经退行性疾病,中枢神经系统(CNS)
Current Alzheimer Research
Title:Potential Application of Centrifuges to Protect the CNS in Space and on Earth
Volume: 15 Issue: 6
关键词: 微重力,超重力,离心机,治疗,空间,老年人,神经退行性疾病,中枢神经系统(CNS)
摘要: Objective: Centrifuges are the principal means of generating physiological hypergravity and have been used for many medical purposes, including the therapy of psychiatric diseases and evaluation of vestibular system in the pilots. In particular, modern centrifuges have evolved into mechanically sophisticated precision instruments compared to primitive ones in old times, indicating that centrifuges might possess great potential in modern medicine. Indeed, studies are in progress to apply centrifuges to musculoskeletal degenerative diseases, such as osteoporosis and sarcopenia. Given that the agingrelated diseases are manifested under microgravity conditions, including astronauts and the bed-ridden elderly, it is reasonable to speculate that centrifuge-induced hypergravity may counteract the progression of these diseases. Such a view may also be important for neurodegenerative diseases for which the radical treatments are yet to be established. Therefore, the main objective of this paper is to discuss a potential therapeutic use of centrifuges for protection against the central nervous system (CNS) disorders, both in space and on Earth. Mechanistically hypergravity may exert stimulatory effects on preconditioning, chaperone expression, synapse plasticity, and growth and differentiation in the nervous system. Furthermore, hypergravity may suppress the progress of type II diabetes mellitus (T2DM), leading to inhibition of T2DM–triggered CNS disorders, including neurodegenerative diseases, ischemia and depression.
Conclusion: Moreover, it is possible that hypergravity may counteract the neurodegeneration in hippocampus induced by the microgravity conditions and psychiatric diseases. Collectively, further investigations are warranted to demonstrate that centrifuge-induced hypergravity may be beneficial for the therapy of the CNS disorders.
Export Options
About this article
Cite this article as:
Potential Application of Centrifuges to Protect the CNS in Space and on Earth, Current Alzheimer Research 2018; 15 (6) . https://dx.doi.org/10.2174/1567205015666171229225501
DOI https://dx.doi.org/10.2174/1567205015666171229225501 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents
Current Medicinal Chemistry Editorial [ Cardiovascular Risk Factor Modification: A sine qua non in the Management of Vascular Surgery Patients ]
Current Vascular Pharmacology Novel Approach to Treat Insulin Resistance, Type 2 Diabetes, and the Metabolic Syndrome: Simultaneous Activation of PPARα, PPARγ, and PPARδ
Current Diabetes Reviews A Refined Framework for Precision and Translational Proteomics in Clinical Research
Current Proteomics Diabetes Mellitus as a Risk Factor for Cancer: Stress or Viral Etiology?
Infectious Disorders - Drug Targets Podocytes as a Target of Insulin
Current Diabetes Reviews The New Immunosuppression: Intervention at the Dendritic Cell-T-Cell Interface
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Non-Analgesic Effects of Opioids: Opioid-induced Nausea and Vomiting: Mechanisms and Strategies for their Limitation
Current Pharmaceutical Design Marine Algae As A Prospective Source For Antidiabetic Compounds – A Brief Review
Current Diabetes Reviews Multiple Roles of Fibroblast Growth Factor 21 in Metabolism
Current Pharmaceutical Design Mediterranean Diet And Longevity: An Example Of Nutraceuticals?
Current Vascular Pharmacology Growing Burden of Diabetes in Sub- Saharan Africa: Contribution of Pesticides ?
Current Diabetes Reviews Possibilities and Limits of Ovarian Reserve Testing in ART
Current Pharmaceutical Biotechnology The Role of Statins in Oxidative Stress and Cardiovascular Disease
Current Drug Targets - Cardiovascular & Hematological Disorders Polymorphism in Endothelin-1 Gene: An Overview
Current Clinical Pharmacology Effects of Fatty Acids and Glycation on Drug Interactions with Human Serum Albumin
Current Metabolomics The Role of Fibrate Treatment in Dyslipidemia: An Overview
Current Pharmaceutical Design Diagnosis and Treatment of Dyslipidaemias in Athletes
Current Vascular Pharmacology Evaluation of Antidiabetic Activity of Carnosol (Phenolic Diterpene in Rosemary) in Streptozotocin-Induced Diabetic Rats
Cardiovascular & Hematological Disorders-Drug Targets Prepubertal IGF-1 and Possible Relation with Physical Features of Growth and Type 1 Diabetes Mellitus
Current Diabetes Reviews